Cargando…
The Glycosylphosphatidylinositol biosynthesis pathway in human diseases
Glycosylphosphatidylinositol biosynthesis defects cause rare genetic disorders characterised by developmental delay/intellectual disability, seizures, dysmorphic features, and diverse congenital anomalies associated with a wide range of additional features (hypotonia, hearing loss, elevated alkaline...
Autores principales: | Wu, Tenghui, Yin, Fei, Guang, Shiqi, He, Fang, Yang, Li, Peng, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254680/ https://www.ncbi.nlm.nih.gov/pubmed/32466763 http://dx.doi.org/10.1186/s13023-020-01401-z |
Ejemplares similares
-
Biosynthesis and deficiencies of glycosylphosphatidylinositol
por: KINOSHITA, Taroh
Publicado: (2014) -
Rescue of Glycosylphosphatidylinositol-Anchored Protein
Biosynthesis Using Synthetic Glycosylphosphatidylinositol Oligosaccharides
por: Guerrero, Paula A., et al.
Publicado: (2021) -
Genome-Wide Screening of Genes Required for Glycosylphosphatidylinositol Biosynthesis
por: Rong, Yao, et al.
Publicado: (2015) -
Cross-talks of glycosylphosphatidylinositol biosynthesis with glycosphingolipid biosynthesis and ER-associated degradation
por: Wang, Yicheng, et al.
Publicado: (2020) -
Spectrum of Neurological Symptoms in Glycosylphosphatidylinositol Biosynthesis Defects: Systematic Review
por: Paprocka, Justyna, et al.
Publicado: (2022)